Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast ophthalmic solution in dry eye disease
CTR20213119Phase 3Completed
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lifitegrast in dry eye syndrome (DED), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Started Dec 2021; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20213119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213119.